BRPI0906484A2 - isolado de ovo fertilizado e seus usos - Google Patents

isolado de ovo fertilizado e seus usos

Info

Publication number
BRPI0906484A2
BRPI0906484A2 BRPI0906484A BRPI0906484A BRPI0906484A2 BR PI0906484 A2 BRPI0906484 A2 BR PI0906484A2 BR PI0906484 A BRPI0906484 A BR PI0906484A BR PI0906484 A BRPI0906484 A BR PI0906484A BR PI0906484 A2 BRPI0906484 A2 BR PI0906484A2
Authority
BR
Brazil
Prior art keywords
fertilized egg
egg isolate
isolate
fertilized
egg
Prior art date
Application number
BRPI0906484A
Other languages
English (en)
Inventor
David Weissman Arthur
Chen Hao
Bain Jerald
Sadavoy Joel
Original Assignee
United Paragon Ass Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Paragon Ass Inc filed Critical United Paragon Ass Inc
Publication of BRPI0906484A2 publication Critical patent/BRPI0906484A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
BRPI0906484A 2008-01-11 2009-01-09 isolado de ovo fertilizado e seus usos BRPI0906484A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2054108P 2008-01-11 2008-01-11
US3318408P 2008-03-03 2008-03-03
PCT/CA2009/000019 WO2009086634A1 (en) 2008-01-11 2009-01-09 Fertilized egg isolate and use thereof

Publications (1)

Publication Number Publication Date
BRPI0906484A2 true BRPI0906484A2 (pt) 2017-06-13

Family

ID=40852735

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906484A BRPI0906484A2 (pt) 2008-01-11 2009-01-09 isolado de ovo fertilizado e seus usos

Country Status (13)

Country Link
US (3) US20110020466A1 (pt)
EP (1) EP2244716B1 (pt)
JP (2) JP2011509262A (pt)
KR (1) KR20100136963A (pt)
CN (2) CN105168254A (pt)
AU (1) AU2009203874B2 (pt)
BR (1) BRPI0906484A2 (pt)
CA (1) CA2749333C (pt)
MX (1) MX2010007539A (pt)
NZ (1) NZ587273A (pt)
RU (1) RU2521348C2 (pt)
WO (1) WO2009086634A1 (pt)
ZA (1) ZA201005727B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471827B (en) * 2009-05-11 2013-11-20 Med Eq As Treatment of stress
SG178964A1 (en) 2009-09-04 2012-04-27 United Paragon Associates Inc Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059230A (en) * 1964-12-08 1967-02-15 Arthur Samy Improvements in or relating to therapeutic products
US5641517A (en) * 1992-07-29 1997-06-24 Drymed As Composition comprising fertilized shell eggs
FR2721481B1 (fr) * 1994-06-27 1996-09-06 Inst Rech Biolog Sa Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel.
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US20010033869A1 (en) * 1996-11-20 2001-10-25 Drymed As Utilization of an egg-based preparation as an antidepressant
NO303819B1 (no) * 1996-11-20 1998-09-07 Drymed As Anvendelse av t°rkede, fertiliserte h°nse-egg for fremstilling av anti-depressive midler
FR2762993B1 (fr) * 1997-05-06 1999-08-13 Inst Rech Biolog Sa Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
JP2001302521A (ja) 2000-04-24 2001-10-31 Yasutaka Sakamoto 鳥類胚抽出物を人体に応用するビジネスモデル
RU2197251C2 (ru) * 2001-04-17 2003-01-27 Тимченко Людмила Дмитриевна Способ приготовления биостимулятора эмбрионального
FR2824828B1 (fr) * 2001-05-21 2005-05-20 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
JP2006176421A (ja) * 2004-12-21 2006-07-06 Kenko Kazoku:Kk ニンニク卵黄を含有する脳機能及び／又は血液流動性改善用組成物
US20070087437A1 (en) * 2005-10-14 2007-04-19 Jifan Hu Methods for rejuvenating cells in vitro and in vivo
WO2007108695A1 (en) * 2006-03-22 2007-09-27 Memoran As Preparation for prophylactic or therapeutic treatment of lapse of memory
GB2471827B (en) * 2009-05-11 2013-11-20 Med Eq As Treatment of stress
US20110200737A1 (en) * 2010-02-15 2011-08-18 Winston Suyanto Composition to enhance cognitive activity

Also Published As

Publication number Publication date
US11285178B2 (en) 2022-03-29
EP2244716A4 (en) 2011-12-21
CN101969965A (zh) 2011-02-09
EP2244716A1 (en) 2010-11-03
EP2244716B1 (en) 2019-09-25
JP2011509262A (ja) 2011-03-24
US20170056453A1 (en) 2017-03-02
ZA201005727B (en) 2013-02-27
MX2010007539A (es) 2010-10-05
CN105168254A (zh) 2015-12-23
CA2749333C (en) 2021-03-23
US20110020466A1 (en) 2011-01-27
RU2010133518A (ru) 2012-02-20
US20190105355A1 (en) 2019-04-11
RU2521348C2 (ru) 2014-06-27
AU2009203874B2 (en) 2014-08-21
WO2009086634A1 (en) 2009-07-16
JP2014224144A (ja) 2014-12-04
JP6262096B2 (ja) 2018-01-17
AU2009203874A1 (en) 2009-07-16
AU2009203874A2 (en) 2010-09-09
NZ587273A (en) 2013-04-26
KR20100136963A (ko) 2010-12-29
CA2749333A1 (en) 2010-07-16

Similar Documents

Publication Publication Date Title
BR112012000660A2 (pt) compostos heterociclos e seus usos
BRPI0910746A2 (pt) reticuladores e seus usos
BRPI0919403A2 (pt) polipeptídeos modificados de eritropoetina animal e seus usos
BRPI1012321A2 (pt) anticorpos anti-vegf e seus usos
BR112012004802A2 (pt) polipeptídeos tendo atividade oxirredutase e seus usos
BRPI0817881A2 (pt) Compostos orgânicos e seus usos
BRPI1016150A2 (pt) compostos heterocíclicos e seus usos.
BR112012003847A2 (pt) imageamento e avaliação de embriões, oócitos e células tronco
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BRPI0921862A2 (pt) inibidores de raf e seus usos
BRPI0913640A2 (pt) substâncias policrômicas e seus usos
PL2538215T3 (pl) Sposób prześwietlania jaj
BRPI0817234A2 (pt) Análogos de azacitidina e seus usos
BRPI0906387A2 (pt) Anticorpos alfa 5 - beta 1 e seus usos
BRPI0710878A2 (pt) Compostos orgânicos e seus usos
BRPI0815381A2 (pt) Aparelho de transferência de ovos
BR112012001080A2 (pt) Combinações de substâncias ativas sinérgicas contendo feniltriazóis
BR112013014067A2 (pt) colchão de molas internas divisórias e suporte
BR112012004402A2 (pt) glicosilação de proteína
BRPI0910514A2 (pt) bactérias recombinantes para produção de deoxiviolaceína e seus usos.
BRPI0910476A2 (pt) composições de vacinas para tratamento de febre do dengue e seus usos
NO330203B2 (no) Merdkonstruksjon
BRPI0716733A2 (pt) Compostos orgânicos e seus usos
BRPI0906484A2 (pt) isolado de ovo fertilizado e seus usos
BRPI1015310A2 (pt) derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]